The investment is expected to boost the company’s position in the industry for sterile packaging, offering customers in Europe and North America comprehensive healthcare solutions
Packaging solution provider Amcor has announced an investment to establish new thermoforming capabilities for medical packaging in its healthcare packaging facility in Sligo, Ireland.
With the investment, the Sligo facility will include Class 7 cleanroom manufacturing environments and thermoforming operations, fully certified to ISO 13485 standards as well as adhering to the regulatory requirements.
Furthermore, the packaging firm will create a full design studio to support product development, allowing customers to gain access to local and global expertise and resources across the company’s network of global innovation centres and thermoforming facilities in Mankato and Puerto Rico, North America.
Amcor chief commercial officer Peter Konieczny said: “The additional capabilities in our Sligo site allow us to provide customers with even more differentiated and efficient solutions to meet their healthcare packaging needs.
“With our global scale and innovation capabilities, Amcor is uniquely positioned to capture growing demand for both medical and pharmaceutical packaging products globally.”
The investment is expected to boost the company’s position in the industry for sterile packaging, offering customers in Europe and North America comprehensive healthcare solutions.
It is expected to double the revenue of the site, increase the site’s footprint and create about 75 new positions, said the company.
Amcor Flexibles Sligo plant general manager John McSharry said: “This is an extremely exciting and proud moment for us. The significant investment in our Sligo site showcases the confidence in the outstanding expertise and dedication of our people.
“Over the coming weeks and months, we will be advertising new roles and look forward to welcoming new colleagues and growing our great team.”